Tasly Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001C81
CNY
15.35
-0.09 (-0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
2,193.05
2,027.88
1,999.80
2,063.60
2,286.71
2,022.09
2,066.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,193.05
2,027.88
1,999.80
2,063.60
2,286.71
2,022.09
2,066.13
Raw Material Cost
754.57
727.57
695.09
771.39
793.28
715.95
751.02
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.32
12.45
1.07
10.15
19.81
30.25
15.61
Selling and Distribution Expenses
857.10
799.00
861.12
811.19
838.29
753.04
851.86
Other Expenses
10.69
16.50
23.56
15.56
12.35
14.14
31.40
Total Expenditure (Excl Depreciation)
1,725.92
1,704.00
1,792.84
1,748.31
1,774.84
1,640.65
1,932.45
Operating Profit (PBDIT) excl Other Income
467.1
323.9
207
315.3
511.9
381.4
133.7
Other Income
32.66
66.37
50.30
44.06
46.73
40.36
53.66
Operating Profit (PBDIT)
613.18
503.74
188.86
443.33
686.06
549.48
308.04
Interest
7.32
12.45
1.07
10.15
19.81
30.25
15.61
Exceptional Items
35.43
42.18
42.58
-83.90
-83.78
-3.95
-81.00
Gross Profit (PBDT)
1,438.49
1,300.31
1,304.71
1,292.21
1,493.43
1,306.14
1,315.11
Depreciation
113.38
113.38
124.30
124.30
126.94
126.94
128.63
Profit Before Tax
527.90
420.08
106.06
224.98
455.52
388.33
82.81
Tax
38.97
75.88
41.21
28.89
58.13
81.41
0.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
460.39
314.31
113.38
179.89
367.10
295.21
38.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
460.39
314.31
113.38
179.89
367.10
295.21
38.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.70
17.78
-82.47
-4.76
-7.10
-2.20
-22.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
457.69
332.08
30.91
175.13
360.00
293.01
16.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,377.39
11,919.98
11,903.33
12,706.97
12,531.09
12,658.47
12,368.42
Earnings per share (EPS)
0.31
0.21
0.08
0.12
0.25
0.2
0.03
Diluted Earnings per share
0.31
0.21
0.08
0.12
0.25
0.2
0.03
Operating Profit Margin (Excl OI)
21.3%
15.98%
0.71%
13.32%
22.41%
18.9%
6.09%
Gross Profit Margin
29.24%
26.31%
11.52%
16.93%
25.47%
25.48%
10.23%
PAT Margin
20.99%
15.5%
5.67%
8.72%
16.05%
14.6%
1.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 8.15% vs 1.41% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 37.82% vs 974.76% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 32.72% vs 215.58% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -41.60% vs 1,036.36% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Tasly Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,193.05
0
2,193.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,193.05
0
2,193.05
Raw Material Cost
754.57
0
754.57
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.32
0
7.32
Selling and Distribution Expenses
857.10
0
857.10
Other Expenses
10.69
0.00
10.69
Total Expenditure (Excl Depreciation)
1,725.92
0
1,725.92
Operating Profit (PBDIT) excl Other Income
467.13
0.00
467.13
Other Income
32.66
0
32.66
Operating Profit (PBDIT)
613.18
0
613.18
Interest
7.32
0
7.32
Exceptional Items
35.43
0
35.43
Gross Profit (PBDT)
1,438.49
0
1,438.49
Depreciation
113.38
0
113.38
Profit Before Tax
527.90
0
527.90
Tax
38.97
0
38.97
Provisions and contingencies
0
0
0.00
Profit After Tax
460.39
0
460.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
460.39
0
460.39
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.70
0
-2.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
457.69
0
457.69
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,377.39
0
12,377.39
Earnings per share (EPS)
0.31
0
0.31
Diluted Earnings per share
0.31
0
0.31
Operating Profit Margin (Excl OI)
21.30%
0%
0.00
21.30%
Gross Profit Margin
29.24%
0%
0.00
29.24%
PAT Margin
20.99%
0%
0.00
20.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 219.31 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 8.15% vs 1.41% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -4.09% vs 0.63% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 45.77 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 37.82% vs 974.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 27.14% vs -15.13% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.05 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 32.72% vs 215.58% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -9.20% vs 12.99% in Jun 2024

Quarterly - Interest
Interest 0.73 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -41.60% vs 1,036.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -63.13% vs 10.61% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.30%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024